The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
Mark Duggan, Fiona Scott Morton
American Economic Review · 2010 · Volume 100 · Issue 1
Abstract
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical prices, the government contracted with private insurers to provide drug coverage. Theory suggests that additional insured consumers will raise the optimal price of a branded drug, while the insurer's ability to move demand to substitute treatments may lower prices. We estimate the program's effect on the price and utilization of pharmaceutical treatments. We find that Part D enrollees paid substantially lower prices than while uninsured, and increased their utilization of prescription drugs. We find relative price declines only for drugs with significant therapeutic competition. (L18, L11, L65)
Keywords
Health: Government Policy, Regulation, Public Health, Production, Pricing, and Market Structure, Size Distribution of Firms, Chemicals, Rubber, Drugs, Biotechnology
Enable JavaScript for citation tools and additional paper interactions.